Table 2.

	Baseline (IQD) n = 30	After 8 weeks of treatment (IQD) n = 28	Wilcoxon signed ranks Test
Median frequency/day	11.7 (9.3–13.4)	9.5 (6.9–10.9)	P = .000
Median volume voided/void	121.9 (103.1–152.9)	155.3 (103.1–198.2)	P = .000
Median incontinence episodes/day	1.3 (0.0–2.7)	0.2 (0.0–1.7)	P = .360
Median no. pads used/day	2.0 (0.0–3.4)	1.0 (0.0–2.0)	P = .010
Median severity of urine loss (0–3; daily added score)	1.2 (0.0–5.0)	0.3 (0.0–2.8)	P = .053
Median degree of urgency prior to voiding (0–3; daily added score)	36.3 (28.8–47.3)	23.7 (18.0–31.0)	P = .000